Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest GUSTO data tips balance back to angioplasty

This article was originally published in Clinica

Executive Summary

The final results of the GUSTO-2b(*) substudy, which compared primary angioplasty with thrombolysis in heart attack patients, now suggest that angioplasty is significantly better. The final results were presented at the European Society of Cardiology meeting in Birmingham by Dr Amadeo Betriu from the Provincial Hospital Clinica in Barcelona. Dr Betriu emphasised that the benefit is small, despite its statistical significance. The composite event rate for thrombolysis patients was 13.7% compared with 9.6% for primary angioplasty.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT089017

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel